Stress – Protective Action

Stress is a phenomenon that manifests itself in our bodies in many different ways.  Some of the more common symptoms of stress include problems with sleep, depression, anxiety, irritability and lethargy.  Along with the physical symptoms, the body also has more fundamental biological responses to stress. At the cellular level, stress affects our ability to properly transform glucose into energy.  Beta-lipa-proteins build up and inhibit the passage of energy through all the cell walls.  This reduced energy level not only affects our ability to perform physical functions, but also inhibits the proper function of all the body’s organs – including the brain.

Perhaps the single most important property of adaptogenic plants is their proven ability to combat stress in all forms.  Eleutherococcus, the strongest of the adaptogenic plants, increases the body’s resistance to a variety of stressors.  Experiments have conclusively demonstrated that Eleutherococcus changes the course of the primary physiological indictors of stress by reducing the activation of the adrenal cortex.

Rhodiola rosea leads to an increase in the amount of basic b-endorphon in the blood plasma, which inhibits the hormonal changes indicative of stress.

Research by the following scientists shows that adaptogens, which are an integral part of the LifeScience product formulation, allow the body to more ably cope with stress, whether it is daily, extreme, acute or chronic.

Researchers                                                Institutes

I.I. Brekhman                   Institute of Biologically Active Substances
O.I. Kirillov                        Siberian Department of the USSR Academy of Sciences
                                              Vladivostok, Russia

Y. Ikeya                                Tsumura Laboratory
H. Taguchi                           Ibaragi, Japan

L.R. Galushkina                  I.M. Sechenov First Moscow Medical Institute
E.V. Kryukovskaya               Moscow, Russia

N. Takasugi                         Central Institute of Wakunaga
T. Moriguchi                         Pharmaceutical Co., Ltd.
T. Fuwa                                 Hiroshima, Japan

N. Singh                                Department of Pharmacology and Therapeutics
P. Verma                               King George’s Medical College
N. Mishra                              Lucknow, Russia

S.I. Chernysh                      Leningrad University
V.A. Lukhtanov                    Leningrad, Russia

A. Nishibe                             Faculty of Pharmaceutical Sciences
H. Kinoshita                         Higashi Nippon Gakuen University Hokaido, Japan

Yu. B. Lishmanov               Lab. Radionucl. Method Res.
L.V. Maslova                        All-Union Cardiol Science Center Tomsk, Russia

N. Nishiyama                     Experimental Station for Medical Plant
T. Kamegaya                     Studies, Faculty of Pharmaceutical Science
A. Iwai                                  University of Tokyo, Japan

S. Sanada                            Department of Pharmacology
Y. Ida                                    Showa University, Japan
J. Shoji